TapImmune has entered into a definitive merger agreement to acquire Marker Therapeutics, a privately-held clinical-stage developer of a transformative, non-genetically engineered, multi-antigen T cell therapy platform.
AlgEternal Ups Production With OriginClear Technology
Clinicians in the not-too-distant future may have something new to offer women with breast cancer and ovarian cancer in whom initial therapy fails to yield a response.
TapImmune will be hosting an investor breakfast at the Blackstone hotel tomorrow, May 17th from 7:30am-10am. Come and meet with with Marker Co-Founders Juan Vera, M.D. and Ann Leen, Ph.D., and former President of the American Society for Gene and Cell Therapy Malcolm Brenner along with TapImmune Management. Read: TapImmune, Marker Merger to Significantly Disrupt…Details
TapImmune has snapped up privately-owned Marker Therapeutics to create a new company based on a non-genetically engineered, multi-antigen T cell therapy platform.
Live Audio Webcast Scheduled for May 17th at 8:00 a.m. CST JACKSONVILLE, Florida – May 15, 2018 – TapImmune Inc. (NASDAQ: TPIV), a leading clinical-stage immuno-oncology company, today announced that it will host a breakfast meeting for analysts and investors this Thursday, May 17, 2018, at the Blackrock Hotel in Chicago. During the meeting, experts…Details
TapImmune is planning to raise money to support its expanded pipeline.
TapImmune expanded its immuno-oncology capabilities today with a deal to acquire Marker Therapeutics and its clinical-stage, multi-antigen T cell therapy platform.
TapImmune, the Jacksonville-based developer of cancer fighting immunotherapies, is merging with Marker Therapeutics Inc., a Minnesota-based developer of similar T-cell therapies.
Progressive Water Treatment’s revenue performance continues into 2018 Los Angeles, CA – May 15, 2018 – OriginClear Inc . (OTC/QB: OCLN ), a leading provider of water treatment solutions, today issued preliminary guidance that revenue for the three months ended March 31, 2018 for its Dallas-based subsidiary, Progressive Water Treatment (PWT), increased by 87 percent…Details
Longtime partner producing pure algae for agricultural and cosmetic applications. La Grange, TX and Los Angeles, CA – May 9, 2018 – OriginClear Inc . (OTC/QB: OCLN ) and AlgEternal Technologies , a vertically-integrated producer of non-fuel high value products from microalgae, recently announced a formal licensing partnership after five years of continuous operation of…Details